Call for applications: UK BIRCWH program scholar position open

Building interdisciplinary research careers in women's health
The University of Kentucky's BIRCWH program supports young scholars in developing meaningful research careers in many areas of women's health.

LEXINGTON, Ky. (Feb. 14, 2024) — The University of Kentucky Building Interdisciplinary Research Careers in Women’s Health (BIRCWH) program is accepting applications for scholars interested in research to advance women’s health.

Applications are being accepted through March 14 for one scholar position beginning August 2024. You can find more information about the application process online here.

Scholars are appointed for two years. Each applicant will develop a specific research project that will be funded by this program and has the potential for further funding.

UK’s program is entering its 24th year as a founding NIH BIRCWH program with recent funding from the National Institute on Drug Abuse (NIDA) under the National Institute of Health (NIH).

The program offers numerous resources, including mentorship, networking, professional and career development, and manuscript and grant writing assistance. The goal is to support BIRCWH members on their trajectory to becoming independent and funded women’s health researchers.

The NIH training grant covers 50% to 75% of a scholar’s protected time to focus on research to accomplish these goals.

The BIRCWH program provides research and personal support for scholars through regular interactions. The research community includes UK faculty with interconnected research interests at similar points in their careers.

Anyone with questions about the UK BIRCWH program can contact Emily Clear (

The BIRCWH program constitutes one element of a broader and growing federal focus on advancing research in women’s health and sex differences. The NIH Office of Research on Women's Health, which houses the BIRCWH program, was established 32 years ago to better include women and women’s health in clinical research and science.

Research reported in this publication was supported by the National Institute on Drug Abuse of the National Institutes of Health under Award Number K12DA035150. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.

UK HealthCare is the hospitals and clinics of the University of Kentucky. But it is so much more. It is more than 10,000 dedicated health care professionals committed to providing advanced subspecialty care for the most critically injured and ill patients from the Commonwealth and beyond. It also is the home of the state’s only National Cancer Institute (NCI)-designated Comprehensive Cancer Center, a Level IV Neonatal Intensive Care Unit that cares for the tiniest and sickest newborns, the region’s only Level 1 trauma center and Kentucky’s top hospital ranked by U.S. News & World Report.

As an academic research institution, we are continuously pursuing the next generation of cures, treatments, protocols and policies. Our discoveries have the potential to change what’s medically possible within our lifetimes. Our educators and thought leaders are transforming the health care landscape as our six health professions colleges teach the next generation of doctors, nurses, pharmacists and other health care professionals, spreading the highest standards of care. UK HealthCare is the power of advanced medicine committed to creating a healthier Kentucky, now and for generations to come.